These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7728496)
61. Should perindopril be used to treat patients with heart failure? Perdikis DA; Mangiaracina G Am Fam Physician; 2002 May; 65(9):1742, 1747. PubMed ID: 12018799 [No Abstract] [Full Text] [Related]
62. [ACE inhibitors in cardiac insufficiency and myocardial infarct. What happens after myocardial infarct?]. Z Kardiol; 1994 Nov; 83(11 Suppl):1-4. PubMed ID: 9209543 [No Abstract] [Full Text] [Related]
63. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension. Weir MR J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504 [TBL] [Abstract][Full Text] [Related]
64. Quinapril: a double-blind, placebo-controlled trial in essential hypertension. Maclean D Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581 [TBL] [Abstract][Full Text] [Related]
65. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661 [TBL] [Abstract][Full Text] [Related]
70. Effect of short-term treatment with bumetanide, quinapril and low-sodium diet on dogs with moderate congestive heart failure. Martinez-Alcaine MA; Ynaraja E; Corbera JA; Montoya JA Aust Vet J; 2001 Feb; 79(2):102-5. PubMed ID: 11256277 [TBL] [Abstract][Full Text] [Related]
71. [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C; Priori SG; Alonso García MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Fernández Burgos E; Lekakis J; Lindahl B; Mazzotta G; McGregor K; Morais J; Oto A; Smiseth OA; Ardissino D; Avendano C; Blomström-Lundqvist C; Clément D; Drexler H; Ferrari R; Fox KA; Julian D; Kearney P; Klein W; Köber L; Mancia G; Nieminen M; Ruzillo W; Simoons M; Thygesen K; Tognoni G; Tritto I; Wallentin L; ; Rev Esp Cardiol; 2004 Dec; 57(12):1213-32. PubMed ID: 15617645 [No Abstract] [Full Text] [Related]
72. Clinical restenosis trials: a perspective from the pharmaceutical industry. Uprichard AC; Texter M; Canter D Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305 [No Abstract] [Full Text] [Related]
73. Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart. Mann DL Cardiovasc Drugs Ther; 2002 Jan; 16(1):7-9. PubMed ID: 12085982 [No Abstract] [Full Text] [Related]
74. [Metabolic effects of quinapril in hepertensive patients]. Zonis BIa; Volkova NI; Martirosov VIu; Kharakhashian AV Ter Arkh; 2000; 72(1):45-7. PubMed ID: 10687206 [TBL] [Abstract][Full Text] [Related]
75. [Summary of seminar on renin-angiotensin system and angiotensin converting enzyme inhibitor]. Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):70-3. PubMed ID: 7767770 [No Abstract] [Full Text] [Related]
76. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors? Malik RA Ann Med; 2000 Feb; 32(1):1-5. PubMed ID: 10711571 [TBL] [Abstract][Full Text] [Related]
77. What to expect from ACE inhibitors after myocardial infarction. Ball SG; Hall AS Br Heart J; 1994 Sep; 72(3 Suppl):S70-4. PubMed ID: 7946808 [No Abstract] [Full Text] [Related]